NAMA
CDNA icon

Nikko Asset Management Americas’s CareDx CDNA Stock Holding History

Nikko Asset Management Americas’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.8M Sell
1,188,075
-287,051
-19% -$6.25M 0.44% 54
2026
Q1 		$25.6M Buy
1,475,126
+28,510
+2% +$540K 0.36% 55
2025
Q4 		$27.3M Sell
1,446,616
-293,448
-17% -$4.92M 0.32% 64
2025
Q3 		$25.3M Buy
1,740,064
+504,473
+41% +$7.19M 0.25% 78
2025
Q2 		$24.1M Sell
1,235,591
-141,163
-10% -$2.51M 0.24% 70
2025
Q1 		$24.4M Sell
1,376,754
-121,264
-8% -$2.61M 0.31% 60
2024
Q4 		$32M Sell
1,498,018
-154,741
-9% -$3.76M 0.35% 54
2024
Q3 		$51.6M Sell
1,652,759
-923,502
-36% -$23M 0.58% 45
2024
Q2 		$40M Sell
2,576,261
-172,077
-6% -$2.08M 0.46% 47
2024
Q1 		$29.1M Sell
2,748,338
-126,561
-4% -$1.27M 0.29% 58
2023
Q4 		$34.5M Sell
2,874,899
-149,604
-5% -$1.23M 0.33% 53
2023
Q3 		$21.1M Buy
3,024,503
+87,378
+3% +$807K 0.25% 60
2023
Q2 		$24.9M Buy
2,937,125
+186,657
+7% +$1.56M 0.26% 59
2023
Q1 		$24.2M Buy
2,750,468
+187,308
+7% +$2.4M 0.28% 50
2022
Q4 		$29.2M Buy
2,563,160
+75,999
+3% +$1.13M 0.42% 46
2022
Q3 		$40.7M Buy
2,487,161
+314,136
+14% +$6.74M 0.52% 42
2022
Q2 		$30.4M Buy
2,173,025
+205,791
+10% +$5.71M 0.38% 55
2022
Q1 		$70.8M Buy
1,967,234
+465,319
+31% +$18.1M 0.52% 37
2021
Q4 		$66.6M Buy
1,501,915
+407,962
+37% +$21.3M 0.35% 61
2021
Q3 		$63.7M Sell
1,093,953
-75,463
-6% -$5.75M 0.27% 69
2021
Q2 		$105M Buy
1,169,416
+352,604
+43% +$28M 0.41% 57
2021
Q1 		$55.6M Buy
816,812
+47,749
+6% +$3.71M 0.27% 75
2020
Q4 		$55.7M Buy
769,063
+25,388
+3% +$1.47M 0.32% 64
2020
Q3 		$28M Buy
743,675
+35,535
+5% +$1.2M 0.25% 69
2020
Q2 		$19.1M Sell
708,140
-286,795
-29% -$8.16M 0.25% 62
2020
Q1 		$21.7M Buy
994,935
+385,926
+63% +$8.65M 0.4% 63
2019
Q4 		$13.1M Buy
609,009
+340,797
+127% +$7.82M 0.21% 87
2019
Q3 		$6.06M Buy
+268,212
New +$7.43M 0.11% 112

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nikko Asset Management Americas's CDNA Position: Q2 2026 in Review

Nikko Asset Management Americas reduced its CareDx (CDNA) stake by 19% in Q2 2026, selling an estimated $6.25M and leaving 1,188,075 shares worth $33.8M. The position accounts for 0.44% of the portfolio, ranked #54.

Nikko Asset Management Americas first reported a position in CDNA in Q3 2019 and has held it in 28 quarters since. The position peaked at $105M in Q2 2021. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Nikko Asset Management Americas held 1,188,075 shares of CareDx worth $33.8M as of Q2 2026.
  • Nikko Asset Management Americas sold 287,051 CareDx shares in Q2 2026, an estimated $6.25M.
  • CareDx made up 0.44% of Nikko Asset Management Americas's portfolio in Q2 2026, its #54 holding.
  • Nikko Asset Management Americas first reported a position in CareDx in Q3 2019 and has held it in 28 quarters since.
  • Nikko Asset Management Americas's CareDx position peaked at $105M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Nikko Asset Management Americas's 13F filing for Q2 2026, filed 13 Aug 2026.